Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID I)

Trial Profile

Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (VALID I)

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Sep 2015

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Cytomegalovirus infections; Herpes simplex virus infections; Varicella zoster virus infections
  • Focus Pharmacokinetics
  • Acronyms VALID-I
  • Most Recent Events

    • 02 Sep 2015 Status changed from suspended to completed as reported by ClinicalTrials.gov record.
    • 28 Aug 2013 Planned End Date changed from 1 Feb 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
    • 28 Aug 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top